Garbade, S., Zielonka, M., Mechler, K., Kölker, S., Hoffmann, G. F., Staufner, C., . . . Ries, M. (2020). FDA orphan drug designations for lysosomal storage disorders: A cross-sectional analysis. PLOS ONE, 15(4), . https://doi.org/10.1371/journal.pone.0230898
Chicago Style (17th ed.) CitationGarbade, Sven, Matthias Zielonka, Konstantin Mechler, Stefan Kölker, Georg F. Hoffmann, Christian Staufner, Eugen Mengel, and Markus Ries. "FDA Orphan Drug Designations for Lysosomal Storage Disorders: A Cross-sectional Analysis." PLOS ONE 15, no. 4 (2020). https://doi.org/10.1371/journal.pone.0230898.
MLA (9th ed.) CitationGarbade, Sven, et al. "FDA Orphan Drug Designations for Lysosomal Storage Disorders: A Cross-sectional Analysis." PLOS ONE, vol. 15, no. 4, 2020, https://doi.org/10.1371/journal.pone.0230898.